Her depth of knowledge and experience in the 340B realm will help us better steer our organization and engage clients in more meaningful ways.
SAN ANTONIO, TX, November 04, 2015 /24-7PressRelease/ -- Healthcare technology firm CaptureRx welcomes recognized 340B expert Mary Ellen England as the new Vice President of Sales. England's appointment will help CaptureRx continue the growth and success it has experienced over the past five years.
"We're excited and flattered to have Mary Ellen join us," said Dave Byrd, President and COO of CaptureRx. "Her depth of knowledge and experience in the 340B realm will help us better steer our organization and engage clients in more meaningful ways."
Prior to joining CaptureRx, England served as a senior executive at Rx Strategies. She was also Director of Education and Marketing for Apexus Inc. England is a recognized industry leader and frequent speaker and panelist at 340B industry conferences. In addition, England provided oversight and support to Apexus' 340B training and certification initiatives as well as direction and oversight in other operations areas.
"Our clients are facing unprecedented challenges ranging from regulatory to technology issues," England said. "My goal is to help clients achieve their 340B objectives and provide the educational support to help them succeed."
About CaptureRx: One of the largest 340B administrators in the United States, CaptureRx is a pioneer and technology leader in pharmacy benefit-management processing and automation. Since 1999, the organization has benefitted millions of patients by helping reduce drug costs. The company's innovative and industry standard-setting Cumulus technology supports the mission of safety-net hospitals through contracted pharmacy network-based delivery of Public Health Service 340B, GPO and PAP drugs. To learn more about CaptureRx, please visit www.Capturerx.com.
# # #